Trial intelligence / Profile preview

Levamlodipine vs Amlodipine in Essential Hypertension

NCT01131546Phase 4Completed

Sponsor
Simcere Pharmaceutical Group
Start
Dec 2009
Primary completion
Mar 2011
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Levamlodipine in essential hypertension, sponsored by Simcere Pharmaceutical Group. Started Dec 2009; status: completed.

02

Drugs

Levamlodipine
03

Conditions

essential hypertension

Beyond the preview

Go deeper on NCT01131546.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01131546.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call